Latest Form 144 filings
Officers, directors and other affiliates of a company file Form 144 when they place an order to sell restricted or control shares, if they plan to sell more than 5,000 shares or more than $50,000 worth within three months. It is a notice of a planned sale; officers and directors report the sale itself later on Form 4. 13D, 13G and Form 144 explained
Form 144 notices
Newest first. When a Form 144/A amends a notice, only the amendment is listed.
Filed in the last 365 days (US Eastern dates).
Form 144 filings on Livermore: Jan 4, 2023 to Oct 5, 2026.
Notices with a clearly misreported market value are left out of this list and its totals; they still appear, flagged, on the company's page. A value counts as misreported when the price per share it implies is far above the company's prices in Form 4 trades and 13F filings around the planned sale date.
- Notices
- 413
- Market value to sell
- $1.41B
- Sellers
- 117
- Companies
- 37
- Under 10b5-1 plans
- 220
| Company | Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|---|
| UHSUniversal Health Services Inc | Oct 29, 20254:23 PM ET | Elliot SussmanDirector | 965 | $217.8K | Oct 29, 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ARQTArcutis Biotherapeutics, Inc. | Oct 28, 20254:06 PM ET | Todd F watanabeOfficer | 40.0K | $1.00M | Oct 28, 202510b5-1 | Merrill | SEC |
| ZYBTZhengye Biotechnology Holding Ltd | Oct 22, 20254:10 PM ET | VVAX Holdings LimitedShareholder | 685.0K | $1.79M | Nov 1, 2025 | AC Sunshine Securities LLC | SEC |
| ZYBTZhengye Biotechnology Holding Ltd | Oct 22, 20254:10 PM ET | Vanguards Skyline Holdings LimitedShareholder | 2.28M | $29.4M | Nov 1, 2025 | AC Sunshine Securities LLC | SEC |
| VIRVir Biotechnology, Inc. | Oct 21, 20259:00 PM ET | SVF Endurance (Cayman) Limited10% stockholder | 834.2K | $5.23M | Oct 21, 202510b5-1 | BTIG, LLC | SEC |
| ARTVArtiva Biotherapeutics, Inc. | Oct 17, 20254:17 PM ET | Fred AslanDirector · Officer | 25.5K | $70.6K | Oct 17, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CLGNCollPlant Biotechnologies Ltd | Oct 9, 20254:55 PM ET | Ami SagyShareholder | 140.0K | $308.0K | Oct 10, 2025 | UBS Securities LLC | SEC |
| EXASExact Sciences Corp | Oct 9, 202511:23 AM ET | Herriott JamesOfficer | 1.50K | $90.0K | Oct 9, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Oct 8, 20254:54 PM ET | Herriot TabuteauOfficer | 12.8K | $1.52M | Oct 8, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Oct 7, 20254:43 PM ET | Herriot TabuteauOfficer | 13.4K | $1.59M | Oct 7, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Oct 7, 20254:17 PM ET | Boulding Mark ElliottOfficer | 3.38K | $214.1K | Oct 7, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| PTCTPTC Therapeutics, Inc. | Oct 6, 20255:16 PM ET | Boulding Mark ElliottOfficer | 2.27K | $147.5K | Oct 6, 202510b5-1 | Fidelity Brokerage Services LLC | SEC |
| AXSMAxsome Therapeutics, Inc. | Oct 6, 20254:47 PM ET | Herriot TabuteauOfficer | 19.2K | $2.31M | Oct 6, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |